comparemela.com

Latest Breaking News On - News ratings for mimedx group daily - Page 8 : comparemela.com

StockNews com Downgrades MiMedx Group (NASDAQ:MDXG) to Buy

StockNews.com downgraded shares of MiMedx Group (NASDAQ:MDXG – Free Report) from a strong-buy rating to a buy rating in a report released on Friday. Separately, HC Wainwright reduced their price objective on MiMedx Group from $9.50 to $8.00 in a research report on Wednesday, June 21st. MiMedx Group Stock Up 0.8 % Shares of MiMedx […]

MiMedx Group (NASDAQ:MDXG) Shares Gap Up to $6 35

MiMedx Group, Inc. (NASDAQ:MDXG – Free Report)’s share price gapped up before the market opened on Tuesday . The stock had previously closed at $6.35, but opened at $6.62. MiMedx Group shares last traded at $6.49, with a volume of 282,193 shares traded. Analysts Set New Price Targets MDXG has been the subject of several […]

Zacks Small Cap Analysts Raise Earnings Estimates for MiMedx Group, Inc (NASDAQ:MDXG)

MiMedx Group, Inc. (NASDAQ:MDXG – Get Rating) – Research analysts at Zacks Small Cap increased their FY2025 EPS estimates for MiMedx Group in a report released on Thursday, June 22nd. Zacks Small Cap analyst J. Vandermosten now expects that the company will post earnings of $0.53 per share for the year, up from their previous […]

Analyzing MiMedx Group (NASDAQ:MDXG) and G Medical Innovations (NASDAQ:GMVD)

MiMedx Group (NASDAQ:MDXG – Get Rating) and G Medical Innovations (NASDAQ:GMVD – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, valuation, risk and analyst recommendations. Earnings and Valuation This table compares MiMedx Group […]

Q3 2023 EPS Estimates for MiMedx Group, Inc (NASDAQ:MDXG) Lifted by Analyst

MiMedx Group, Inc. (NASDAQ:MDXG – Get Rating) – Northland Capmk lifted their Q3 2023 EPS estimates for MiMedx Group in a research report issued on Wednesday, June 21st. Northland Capmk analyst C. Byrnes now anticipates that the company will earn $0.02 per share for the quarter, up from their previous estimate of ($0.04). The consensus […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.